25,970 Shares in AmerisourceBergen Corp. (ABC) Purchased by Sawyer & Company Inc

Sawyer & Company Inc acquired a new stake in shares of AmerisourceBergen Corp. (NYSE:ABC) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 25,970 shares of the company’s stock, valued at approximately $2,385,000. AmerisourceBergen makes up 1.6% of Sawyer & Company Inc’s investment portfolio, making the stock its 18th biggest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ABC. Sun Life Financial INC boosted its holdings in shares of AmerisourceBergen by 15,000.0% in the 2nd quarter. Sun Life Financial INC now owns 1,208 shares of the company’s stock worth $114,000 after acquiring an additional 1,200 shares in the last quarter. D.A. Davidson & CO. boosted its holdings in shares of AmerisourceBergen by 29.0% in the 2nd quarter. D.A. Davidson & CO. now owns 1,668 shares of the company’s stock worth $157,000 after acquiring an additional 375 shares in the last quarter. Intl Fcstone Inc. acquired a new position in shares of AmerisourceBergen in the 2nd quarter worth approximately $201,000. Coastline Trust Co acquired a new position in shares of AmerisourceBergen in the 2nd quarter worth approximately $203,000. Finally, Zeke Capital Advisors LLC acquired a new position in shares of AmerisourceBergen in the 3rd quarter worth approximately $210,000. 67.83% of the stock is currently owned by institutional investors.

In related news, SVP Lazarus Krikorian sold 16,427 shares of the firm’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $84.86, for a total value of $1,393,995.22. Following the completion of the sale, the senior vice president now directly owns 23,360 shares in the company, valued at approximately $1,982,329.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard W. Gochnauer sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, January 10th. The shares were sold at an average price of $96.54, for a total transaction of $193,080.00. Following the completion of the sale, the director now owns 12,947 shares of the company’s stock, valued at $1,249,903.38. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 203,823 shares of company stock valued at $17,145,148. Company insiders own 27.40% of the company’s stock.

Several brokerages have recently commented on ABC. Zacks Investment Research downgraded AmerisourceBergen from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Leerink Swann set a $105.00 price objective on AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, January 2nd. Needham & Company LLC upped their price objective on AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a report on Wednesday, November 22nd. Jefferies Group set a $85.00 price objective on AmerisourceBergen and gave the stock a “hold” rating in a report on Sunday, October 29th. Finally, Royal Bank of Canada assumed coverage on AmerisourceBergen in a report on Tuesday, September 19th. They set a “sector perform” rating and a $87.00 price objective on the stock. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $95.96.

AmerisourceBergen Corp. (NYSE:ABC) traded down $0.31 during mid-day trading on Thursday, reaching $97.21. The company’s stock had a trading volume of 1,070,200 shares, compared to its average volume of 1,411,743. The company has a market cap of $21,350.00, a PE ratio of 60.01, a PEG ratio of 1.63 and a beta of 0.99. The company has a debt-to-equity ratio of 1.83, a quick ratio of 0.48 and a current ratio of 0.91. AmerisourceBergen Corp. has a 52-week low of $71.90 and a 52-week high of $97.86.

AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 EPS for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a net margin of 0.27% and a return on equity of 56.29%. The company had revenue of $39.12 billion during the quarter, compared to the consensus estimate of $40.10 billion. During the same period in the prior year, the business posted $1.30 EPS. The company’s quarterly revenue was up 4.2% on a year-over-year basis. equities analysts expect that AmerisourceBergen Corp. will post 6.14 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://stocknewstimes.com/2018/01/11/25970-shares-in-amerisourcebergen-corp-abc-purchased-by-sawyer-company-inc.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply